Re: Bladder Preservation with Twice-a-day Radiation plus Fluorouracil/Cisplatin or Once Daily Radiation plus Gemcitabine for Muscle-invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial
Publication year
2019Author(s)
Source
European Urology, 75, 6, (2019), pp. 1033-1034ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Urology
Journal title
European Urology
Volume
vol. 75
Issue
iss. 6
Page start
p. 1033
Page end
p. 1034
Subject
Radboudumc 15: Urological cancers RIMLS: Radboud Institute for Molecular Life Sciences; Urology - Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [248099]
- Faculty of Medical Sciences [94006]
Upload full text
Use your RU or RadboudUMC credentials to log in with SURFconext to upload a file for processing by the repository team.